Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

403 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunogenicity of Comirnaty Omicron XBB.1.5 booster COVID-19 mRNA vaccine in long-term survivors after allogeneic hematopoietic stem cell transplantation.
Einarsdottir S, Al-Dury S, Fridriksson E, Andius LD, Wang H, Sharba S, Mountagui A, Waern J, Ringlander J, Martner A, Hellstrand K, Waldenström J, Lagging M. Einarsdottir S, et al. Among authors: waldenstrom j. Sci Rep. 2024 Oct 21;14(1):24749. doi: 10.1038/s41598-024-74712-x. Sci Rep. 2024. PMID: 39433814 Free PMC article.
Reduced immunogenicity of a third COVID-19 vaccination among recipients of allogeneic hematopoietic stem cell transplantation.
Einarsdottir S, Martner A, Nicklasson M, Wiktorin HG, Arabpour M, Törnell A, Vaht K, Waldenström J, Ringlander J, Bergström T, Brune M, Hellstrand K, Ljungman P, Lagging M. Einarsdottir S, et al. Among authors: waldenstrom j. Haematologica. 2022 Jun 1;107(6):1479-1482. doi: 10.3324/haematol.2021.280494. Haematologica. 2022. PMID: 35236057 Free PMC article. No abstract available.
Deficiency of SARS-CoV-2 T-cell responses after vaccination in long-term allo-HSCT survivors translates into abated humoral immunity.
Einarsdottir S, Martner A, Waldenström J, Nicklasson M, Ringlander J, Arabpour M, Törnell A, Wiktorin HG, Nilsson S, Bittar R, Nilsson M, Lisak M, Veje M, Friman V, Al-Dury S, Bergström T, Ljungman P, Brune M, Hellstrand K, Lagging M. Einarsdottir S, et al. Among authors: waldenstrom j. Blood Adv. 2022 May 10;6(9):2723-2730. doi: 10.1182/bloodadvances.2021006937. Blood Adv. 2022. PMID: 35286374 Free PMC article.
COVID-19 vaccine-induced adverse events predict immunogenicity among recipients of allogeneic hematopoietic stem cell transplantation.
Wiktorin HG, Einarsdottir S, Törnell A, Arabpour M, Issdisai N, Waldenström J, Ringlander J, Lindh M, Lagging M, Hellstrand K, Martner A. Wiktorin HG, et al. Among authors: waldenstrom j. Haematologica. 2022 Oct 1;107(10):2492-2495. doi: 10.3324/haematol.2022.280813. Haematologica. 2022. PMID: 35734932 Free PMC article. No abstract available.
Impaired SARS-CoV-2-specific T-cell reactivity in patients with cirrhosis following mRNA COVID-19 vaccination.
Al-Dury S, Waern J, Waldenström J, Alavanja M, Saed HH, Törnell A, Arabpour M, Wiktorin HG, Einarsdottir S, Ringlander J, Ringström G, Hellstrand K, Martner A, Lagging M. Al-Dury S, et al. Among authors: waldenstrom j. JHEP Rep. 2022 Jul;4(7):100496. doi: 10.1016/j.jhepr.2022.100496. Epub 2022 Apr 27. JHEP Rep. 2022. PMID: 35502229 Free PMC article.
Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3.
Rembeck K, Waldenström J, Hellstrand K, Nilsson S, Nyström K, Martner A, Lindh M, Norkrans G, Westin J, Pedersen C, Färkkilä M, Langeland N, Buhl MR, Mørch K, Christensen PB, Lagging M. Rembeck K, et al. Among authors: waldenstrom j. Hepatology. 2014 Jun;59(6):2131-9. doi: 10.1002/hep.27009. Epub 2014 Apr 25. Hepatology. 2014. PMID: 24519039 Clinical Trial.
403 results